SurModics Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The company was founded in 1979 and is based in Eden Prairie, Minnesota.
SRDX Price Forecast Based on DCF Valuation
DCF Fair Value Target:
We started the process of determining a valid price forecast for Surmodics Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Surmodics Inc ranked in the 25th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for SRDX, they are:
The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately merely 0.05% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Healthcare).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
A, BIO, ILMN, VIVO, and XRAY can be thought of as valuation peers to SRDX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
Surmodics (SRDX) has received FDA 510(k) clearance for its Pounce Thrombus Retrieval System for the treatment of peripheral artery disease ((PAD)). The Pounce Thrombus is intended for the non-surgical removal of thrombi and emboli from the peripheral arterial vasculature. PAD is a serious and underdiagnosed circulatory condition caused by build-up of...
Surmodics, Inc. (SRDX) Q3 2020 Earnings Conference Call August 5, 2020 17:00 ET Company Participants Tim Arens - Vice President, Finance & Chief Financial Officer Gary Maharaj - Chief Executive Officer Conference Call Participants Jim Sidoti - Sidoti & Company Brooks O'Neil - Lake Street Capital Markets David Saxon -...